Skip to content

Perception of Female Hormonal Contraception by the Main Prescribers

Perception of Female Hormonal Contraception by the Main Prescribers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05528731
Acronym
CHF
Enrollment
385
Registered
2022-09-06
Start date
2022-05-31
Completion date
2023-01-31
Last updated
2023-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Hormonal Contraception

Keywords

Female Hormonal Contraception

Brief summary

The recommendations for contraception, after researching contraindications to certain methods, are to offer clear and honest information to allow the patient to make an informed choice, adapted to her lifestyle. The best contraception is the one chosen by the patient. The choice of contraception illustrates the difficulty of assessing the benefit-risk balance in the context of functional and preventive treatment. Taking into account this imbalance between patient beliefs and medical advice is an essential step in improving the provision of gynecological care.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any health care professional in general medicine, gynecology and midwifery * graduate or in progress * in practice (any practice modality in metropolitan France) * agreeing to participate in the survey by completing the questionnaire anonymously, after having read the information and non-objection notice attached to the questionnaire.

Exclusion criteria

\- Any other health profession Inclusion criteria: \- Any health care professional in general medicine, gynecology and midwifery

Design outcomes

Primary

MeasureTime frame
Study of the perception of risks and management of adverse effects of hormonal contraception among prescribers5 months after interviews with prescribers

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026